AI-assisted CAPA has enormous potential. It also demonstrates perfectly why regulated organisations need to distinguish between assistance and accountability.

AI could analyse historical CAPAs, identify recurring failure modes, suggest related records, highlight overdue patterns, support action drafting and monitor effectiveness indicators.

That could transform CAPA from a largely reactive administrative process into something far more predictive.

But CAPA is also an area where inappropriate reliance on AI could create significant risk.

Consider root cause analysis. An AI system can identify correlations across historical records. It may suggest that a particular equipment condition, material supplier or process step appears frequently in similar events.

That is useful.

But it does not establish causality.

The same applies to corrective actions. AI may propose potential actions based on historical records, but somebody still needs to determine whether those actions are scientifically appropriate, proportionate to risk and likely to prevent recurrence.

This is why human oversight needs to be designed into the workflow rather than added afterwards.

The level of oversight should also be proportionate to risk.

Using AI to summarise a closed investigation may require relatively limited review. Using AI to recommend the root cause of a critical quality event requires substantially more scrutiny. Allowing an autonomous system to close a high-risk CAPA would be an entirely different proposition.

The principle should therefore be:

The greater the potential impact on patient safety, product quality, data integrity or regulatory decision-making, the stronger the human oversight.

FDA’s current AI framework for drug and biological products similarly uses a risk-based credibility approach tied to the model’s context of use. FDA and EMA’s joint good-AI-practice principles also emphasise human-centric design, context of use, multidisciplinary expertise and lifecycle management.

AI-assisted CAPA therefore should not mean autonomous CAPA.

It should mean using AI to remove administrative burden, expand the evidence available to investigators, detect patterns earlier and strengthen human decision-making.

The objective is not to remove people from CAPA.

It is to allow people to spend less time managing the CAPA record and more time solving the quality problem.